Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".
Rice
David
D
University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: drice@mdanderson.org.
Swisher
Stephen
S
University of Texas MD Anderson Cancer Center, Houston, TX.
Pisters
Katherine
K
University of Texas MD Anderson Cancer Center, Houston, TX.
Fossella
Frank
F
University of Texas MD Anderson Cancer Center, Houston, TX.
Herbst
Roy
R
University of Texas MD Anderson Cancer Center, Houston, TX.
Hofstetter
Wayne
W
University of Texas MD Anderson Cancer Center, Houston, TX.
Kies
Merrill
M
University of Texas MD Anderson Cancer Center, Houston, TX.
Komaki
Ritsuko
R
University of Texas MD Anderson Cancer Center, Houston, TX.
Lippman
Scott
S
University of Texas MD Anderson Cancer Center, Houston, TX.
Mehran
Reza
R
University of Texas MD Anderson Cancer Center, Houston, TX.
Roth
Jack
J
University of Texas MD Anderson Cancer Center, Houston, TX.
Stewart
David
D
University of Texas MD Anderson Cancer Center, Houston, TX.
Vaporciyan
Ara
A
University of Texas MD Anderson Cancer Center, Houston, TX.
Walsh
Garrett
G
University of Texas MD Anderson Cancer Center, Houston, TX.
Cox
James
J
University of Texas MD Anderson Cancer Center, Houston, TX.
D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D011013:Pneumonectomy; D015996:Survival Rate; D016896:Treatment Outcome